HALO logo
halo search icon
PHM
Pharma Mar SA

PHM · Pharma Mar SA

68.75

EUR
0.00 (0.00%)
22/06/2026 12:00:00 AM
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

Euro1.21B

PE

17.40

EV/EBITDA

24.6

DIV Yield

1.1%

Payout Ratio

19%

MQV Rating

5Very Weak

As at 22/06/2026 12:00:00 AM

Price Chart

Description

Pharma Mar SA is a biopharmaceutical holding company, which engages in research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It operates through the following segments: Oncology, Diagnostics, and RNAi. The Oncology segment focuses to the group undertakings whose object is to research, develop, and market anti-tumour drugs. The Diagnostics segment focuses in the development and marketing of diagnostic kits. The RNAi segment develops drugs with therapeutic activity based on reducing or silencing gene expression. The company was founded by José Maria Fernández de Sousa-Faro on April 30, 1986 and is headquartered in Colmenar Viejo, Spain.

  • All-Companies
  • All-Consensus
  • Big Candle
  • Consensus Cheap
  • EMA 125 Breakdown
  • Engulfing Bearish
  • HALO 100
  • HALO 200
  • HALO 50
  • HALO All
  • HALO Balance Sheet
  • HALO Consensus Value
  • Near Support
  • Recent Earnings downgrade
  • Recent Price upgrade
  • Volume Spike

Key Fundamentals

EPS 3 yr Growth

57.30%

EBITDA Margin

21.80%

Operating Cashflow

€53m

Free Cash Flow Return

19.70%

ROIC

27.90%

Interest Coverage

19.60

Quick Ratio

2.40

Performance

52 weeks range

Low 64 - 105.2

Trade Value (12mth)

US$1,418,869.00

1 week

0%

1 month

-32.27%

YTD

-10.01%

1 year

-14.06%

All time high

148.00

Additional Data

Shares Outstanding (Fully Diluted)

17m

HALO Sector

Healthcare

Next Company Report Date

02-Mar-27

Next Ex Dividend Date

25-Jun-25

Next Dividend Pay Date

27-Jun-25

Reporting Currency

EUR

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Strong

Quality

Capital Efficiency

Strong

Balance Sheet

Very Strong

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Pharma Mar SA (PHM:MCE)?
Halo FAQ
The current share price of Pharma Mar SA (PHM:MCE) is EUR€68.75.
2
What is the 52-week high share price for Pharma Mar SA (PHM:MCE)?
Halo FAQ
The 52-week high share price for Pharma Mar SA (PHM:MCE) is EUR€105.20.
3
What is the 52-week low share price for Pharma Mar SA (PHM:MCE)?
Halo FAQ
The 52-week low share price for Pharma Mar SA (PHM:MCE) is EUR€64.00.
4
What is the dividend yield for Pharma Mar SA (PHM:MCE)?
Halo FAQ
The current TTM dividend payout for Pharma Mar SA (PHM:MCE) is 1.10.
5
What was Pharma Mar SA (PHM:MCE) last dividend payment?
Halo FAQ
The last dividend payment of Pharma Mar SA (PHM:MCE) is EUR€0.80.
6
What is the franking level for Pharma Mar SA (PHM:MCE)?
Halo FAQ
Pharma Mar SA (PHM:MCE) has a franking level of 0.00%.
7
In which sector is Pharma Mar SA (PHM:MCE) classified?
Halo FAQ
Pharma Mar SA (PHM:MCE) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Pharma Mar SA (PHM:MCE)?
Halo FAQ
The current P/E ratio for Pharma Mar SA (PHM:MCE) is 17.40.